Kisqali 600 MG daily dose UU 63S
Ended Awarded Last action
- Contract number
- SPE2DR26FM0KT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,374
Award facts
- Contract value 100% obligated
- $11,374.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Kisqali 600 mg daily dose medication in the amount of $11,374.42 on December 11, 2025, with a completion date of January 5, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems through its extensive contract portfolio with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This Kisqali delivery order represents a routine procurement transaction leveraging AmerisourceBergen's established pharmaceutical prime vendor relationship with DLA to support the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM0KT?
SPE2DR26FM0KT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FM0KT worth?
The government has obligated $11,374 on SPE2DR26FM0KT.
Is contract SPE2DR26FM0KT an order under another contract?
Yes. SPE2DR26FM0KT is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM0KT competed?
The extent of competition for SPE2DR26FM0KT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award